VBI Vaccines Intangible Assets

VBI Vaccines (VBIV) currently reports a intangible assets of $36M as of March 2024. That compares with $59M in the prior-year period — down 38.9% year over year. Use the charts on this page to explore VBI Vaccines's intangible assets history and peer comparisons.

VBI Vaccines's intangible assets decreased from $59M to $36M — a 38.9% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

VBI Vaccines reported $36M in intangible assets as of March 2024. That compares with $59M in the prior-year period — down 38.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $36M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for VBI Vaccines, and consider following VBIV for alerts when major investors trade the stock.

VBI Vaccines is classified in the Healthcare sector. On intangible assets, it currently shows $36M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VBIV with unrelated industries.